Bullish option flow detected in GSK (GSK) Pharma with 3,057 calls trading, 1.1x expected, and implied vol increasing over 4 points to 29.80%. Feb-25 34 calls and 1/31 weekly 34 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.27. Earnings are expected on February 5th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer
- GSK announces expanded EU approval in endometrial cancer for Jemperli combo
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
- Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy Lined Up for Medicare Drug Price Negotiations
- Ozempic, Xtandi among next 15 drugs selected for U.S. price talks